Blood testing startup Thriva secures $7.35 million Series A funding round to help people control their health
Thriva, a blood testing startup that has developed home blood test kits for people to measure things such as their hormone and mineral level, has secured $7.35 million (£6 million) Series A funding round. The funding will be used to support Thriva as it builds towards its ambitious vision of putting optimal health in anyone’s hands. The round, which comes from a range of investors including Pembroke VCT and Guinness Asset Management, brings the total funding raised to date to £7.5 million.
Founded in 2016 by Hamish Grierson, Eliot Brooks and Tom Livesey, the London, England-based Thriva’s mission to put optimal health in anyone’s hands by providing tools and actionable insights, based on the latest research. Thriva has helped over 100,000 people across the UK proactively manage their health – giving people access to affordable, clinical-grade insights which reveal how their lifestyle is impacting their health. Its at-home testing kits are processed by UKAS accredited laboratories and can analyse anything from vitamins and minerals to hormone function to indicators of heart disease and diabetes. Thriva currently employs 35 people.
Thriva offers affordable, clinical-grade insights based on the latest research and has helped over 100,000 people understand how their lifestyle is impacting their health. The company is fast becoming the go-to brand in the ‘proactive health’ category, an increasingly mainstream movement in which people are actively engaged in pursuing better health.
The company, which was founded by Hamish Grierson, Eliot Brooks and Tom Livesey, continues to grow 100% year-on-year and has expanded its team significantly to 35 team members in the company’s London Headquarters.
Thanks to Thriva, customers can understand, keep track of and improve what’s happening inside their bodies. Its at-home testing kits are processed by UKAS accredited laboratories and can analyse anything from vitamins and minerals to hormone function to indicators of heart disease and diabetes.
Its customers are people who proactively seek out services that go beyond a ‘one-size fits all’ approach to health and are looking for the personalised, actionable insights that Thriva provides.
Hamish Grierson, co-founder and CEO of Thriva said: “Our mission remains the same: To provide anybody with profound control over their own wellbeing. Thriva is creating affordable access to clinical-grade information that show you what steps you can take towards thriving health.
“Most people are still not aware that companies like Thriva exist. That is something we want to change as we build towards a truly consumer-led future of health. Swathes of the population are already proactively seeking improved health, and are waking up to the fact that it’s within their gift to understand and control. It’s a system we see as working in tandem with organisations like the NHS, which offer a crucial service for people at the point of need when sick and/or serious care is needed.”